Biochemical Reagent
-
BA8244 PHGDH-IN-3Summary: PHGDH-IN-3 is a phosphoglycerate dehydrogenase inhibitor with oral activity. - BA8245 PKUMDL-WQ-2201Summary: PKUMDL-WQ-2201 is a non-NAD+ competitive mutation inhibitor (=35.7 μM).
- BA8247 DPTIPSummary: DPTIP is a potent, neutral sphingomyelinase (exosome inhibitor) that crosses the blood-brain barrier.
- BA8248 LFHP-1cSummary: LFHP-1c is an inhibitor with neuroprotective activity in ischemic stroke.
- BA8249 CAY10650Summary: CAY10650 is a potent inhibitor of cytoplasmic phospholipase A2α.
- BA8250 LEI-401Summary: LEI-401 is a first-of-its-kind, selective, blood-brain barrier-crossing inhibitor of (N-acylphosphoethanolamine phospholipase D).
- BA8251 CCT129957Summary: CCT129957 is an indole derivative.
- BA8252 CAY10594Summary: CAY10594 is a potent inhibitor (in vitro = 140 nM
- BA8253 RilapladibSummary: Rilapladib (SB659032) is a selective inhibitor of lipoprotein-associated phospholipase A.
- BA8254 GSK2647544Summary: GSK2647544 is an oral, selective inhibitor.